Estudio de fase I/II de células T autólogas que expresan receptores de células T (TCR) en sujetos con tumores sólidos
5 de abril de 2022
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
